AstraZeneca (AZN)

Add to Watchlists
Create an Alert
36.84 -0.20  -0.55% NYSE May 23, 16:59 Delayed 2m USD

AstraZeneca Cash from Investing (TTM):

-1.909B for March 31, 2018
View 4,000+ financial data types
Browse...
View Full Chart

AstraZeneca Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

AstraZeneca Historical Cash from Investing (TTM) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2018 -1.909B
Dec. 31, 2017 -2.328B
Sept. 30, 2017 -83.00M
June 30, 2017 -372.00M
March 31, 2017 -1.228B
Dec. 31, 2016 -3.969B
Sept. 30, 2016 -7.157B
June 30, 2016 -6.953B
March 31, 2016 -6.57B
Dec. 31, 2015 -4.239B
Sept. 30, 2015 -3.17B
June 30, 2015 -3.311B
March 31, 2015 -3.811B
Dec. 31, 2014 -7.032B
Sept. 30, 2014 -6.52B
June 30, 2014 -6.606B
March 31, 2014 -6.302B
Dec. 31, 2013 -2.889B
Sept. 30, 2013 -2.399B
June 30, 2013 -4.45B
March 31, 2013 -2.816B
Dec. 31, 2012 -1.859B
Sept. 30, 2012 -4.925B
June 30, 2012 -955.00M
March 31, 2012 -1.538B
   
Dec. 31, 2011 -2.022B
Sept. 30, 2011 1.106B
June 30, 2011 92.00M
March 31, 2011 -1.01B
Dec. 31, 2010 -2.226B
Sept. 30, 2010 -3.678B
June 30, 2010 -4.346B
March 31, 2010 -3.657B
Dec. 31, 2009 -2.476B
Sept. 30, 2009 -1.081B
June 30, 2009 -859.00M
March 31, 2009 -899.00M
Dec. 31, 2008 -3.896B
Sept. 30, 2008 -3.823B
June 30, 2008 -3.593B
March 31, 2008 -17.20B
Dec. 31, 2007 -14.89B
Sept. 30, 2007 -14.17B
June 30, 2007 -14.75B
March 31, 2007 1.016B
Dec. 31, 2006 -272.00M
Sept. 30, 2006 -1.119B
June 30, 2006 -1.67B
March 31, 2006 -3.06B
Dec. 31, 2005 -1.182B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

AZN Cash from Investing (TTM) Benchmarks

Benchmarks
GlaxoSmithKline -2.133B
Sanofi --
Bristol-Myers Squibb 94.00M

AZN Cash from Investing (TTM) Range, Past 5 Years

Minimum -7.157B Sep 2016
Maximum -83.00M Sep 2017
Average -4.065B

AZN Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("AZN", "cash_investing_ttm")
  • Last 5 data points: =YCS("AZN", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.